| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |